In a groundbreaking development, surgeons in the UK have ushered in a new era of medical innovation by utilizing Apple's cutting-edge virtual reality goggles to conduct a spinal operation for the first time. The pioneering procedure, used at the Cromwell Hospital in London, marks a significant leap forward in surgical technology and has the potential to revolutionize healthcare … [Read more...] about Spine Surgery with Apple! First surgery using the Vision Pro in London!
2024
Spineart Completes Enrollment in the Baguera®C IDE trial for Two-Level Cervical Disc Replacement
GENEVA, March 8, 2024 /PRNewswire/ -- Spineart SA, manufacturer of the BAGUERA®C Cervical Disc Prosthesis, today announced it has completed enrollment in its U.S. IDE trial studying the BAGUERA®C Cervical Disc Prosthesis in patients with cervical disc disease at two contiguous levels between C3 to C7 compared to a commercially marketed cervical disc implant. The … [Read more...] about Spineart Completes Enrollment in the Baguera®C IDE trial for Two-Level Cervical Disc Replacement
Medtronic advances data-driven spine solutions with AI-powered patient reported outcomes
Medtronic, a global leader in medical technology, announced today the launch of the new UNiD™ ePRO service in the United States. This solution will change the way patient outcomes are collected for spine surgeons, reducing the burden on clinic staff and patients. Medtronic has partnered with OBERD, a leading practice intelligence data collection company, to provide spine … [Read more...] about Medtronic advances data-driven spine solutions with AI-powered patient reported outcomes
Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
BELGRADE, Mont., March 07, 2024 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that the Company’s revolving credit agreement with MidCap Financial Trust (“MidCap”) was amended to increase the commitment from $8.0 million to $17.0 … [Read more...] about Xtant Medical Increases Revolving Credit Facility to $17 Million with MidCap Financial
SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft
BOCA RATON, Fla.--(BUSINESS WIRE)--SurGenTec, a pioneering medical device company specializing in orthopedic and spine technologies, proudly announces the first implantations and 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its revolutionary OsteoFlo HydroPutty Synthetic Bone Graft. OsteoFlo HydroPutty represents a significant advancement in bone … [Read more...] about SurGenTec® Receives FDA Clearance for OsteoFlo® HydroPutty™, a Hydrophilic Synthetic Bone Graft
IMPLANET reports its 2023 full-year results
Bordeaux, Boston, March 6, 2024 – 7:30 am CET: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plan), a medical technology company specialized in implants for orthopedic surgery and the distribution of technological medical equipment, today announced its 2023 full-year results, as of December 31, 2023, as approved by the Board of Directors on … [Read more...] about IMPLANET reports its 2023 full-year results
What is artificial intelligence Already Doing in the Spinal Field? Which AI Companies Are Worth Following?
These days, everyone's talking about artificial intelligence (AI) all the time. But most of us do not know yet what is available today and which are the benefits that the AI offers in the spinal field: Which companies should you keep an eye on in the AI landscape? … [Read more...] about What is artificial intelligence Already Doing in the Spinal Field? Which AI Companies Are Worth Following?
Orthofix Reports Fourth Quarter and Full Year 2023 Results
LEWISVILLE, Texas--(BUSINESS WIRE)-- Orthofix Medical Inc. (NASDAQ:OFIX) today reported its financial results for the fourth quarter and year ended December 31, 2023, and issued guidance for the full year 2024. Fourth quarter net sales were $200.4 million, an increase of 64% on a reported basis and 7% on a pro forma constant currency basis. Net loss was $(22.2) million … [Read more...] about Orthofix Reports Fourth Quarter and Full Year 2023 Results
SpineGuard reaches a significant regulatory milestone to strenghthen its PediGuard® offering in China
SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) unique sensing technology using electrical conductivity local measurement in real time to secure and streamline the placement of bone implants, today announces a key progress in its Chinese regulatory plan with the submission to the Chinese authorities (NMPA) of a … [Read more...] about SpineGuard reaches a significant regulatory milestone to strenghthen its PediGuard® offering in China
How does the EU Medical Devices Regulation (MDR) impact the Spine Market?
The introduction of the Medical Devices Regulation (MDR) by the European Union represents a significant regulatory framework aimed at enhancing patient safety and fostering innovation in the medical device industry. The primary objective is to ensure that all medical devices undergo stringent evaluations to guarantee their safety, a goal with unanimous support among potential … [Read more...] about How does the EU Medical Devices Regulation (MDR) impact the Spine Market?
Alphatec Spine from 1990 to 2024: A Journey of Resilience, Transformation, and Sales Success!
Founded in 1990 by Shunshiro "Roy" Yoshimi, Alphatec Spine initially operated as a medical device contract manufacturer. However, in July 1991, the company opted for vertical integration, pivoting to develop, manufacture, market, and sell its orthopedic trauma products. In 2003, Alphatec Spine expanded its focus to include spinal products. Following its initial success, … [Read more...] about Alphatec Spine from 1990 to 2024: A Journey of Resilience, Transformation, and Sales Success!
Orthofix Announces New President for Bone Growth Therapies Business
LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, today announced the appointment of Jason Shallenberger to President of the Bone Growth Therapies business, and the realignment of its Spine business unit, effective March 1. A seasoned sales leader, Shallenberger previously served as Vice President of U.S. … [Read more...] about Orthofix Announces New President for Bone Growth Therapies Business
Kleiner Device Labs Presents e-Poster at Southern Neurosurgical Society Meeting:”Rethinking Posterior MIS Fusion – Enabling Risk Reduction in Posterior Spinal Surgery”
February 29, 2024 -- Incline Village, Nev., -- Kleiner Device Labs (KDL) today announced that an e-Poster has been accepted for the Southern Neurosurgical Society’s 2024 annual conference beginning on March 7 in Orlando. The e-Poster (#156) highlights research results of new innovations in lumbar spinal implant and … [Read more...] about Kleiner Device Labs Presents e-Poster at Southern Neurosurgical Society Meeting:”Rethinking Posterior MIS Fusion – Enabling Risk Reduction in Posterior Spinal Surgery”
Woven Orthopedics Secures Second FDA spine clearance Ogmend® now available for most pedicle screws diameters
MANCHESTER, Conn., Feb. 29, 2024 /PRNewswire/ -- Woven Orthopedic Technologies, developer of Ogmend®, a simple implantable sleeve that quickly and easily secures stable screw fixation, has received its second 510(k) clearance from the Food and Drug Administration (FDA) for the use of Ogmend® Implant Enhancement System in spine surgery. "We are excited about … [Read more...] about Woven Orthopedics Secures Second FDA spine clearance Ogmend® now available for most pedicle screws diameters
ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
WESTMINSTER, Colo., Feb. 28, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today reported financial results for the quarter and year ended December 31, 2023. Management will host a corresponding conference call today, February 28, 2024, at 4:30 p.m. Eastern Time. “We had significant accomplishments in … [Read more...] about ZimVie Reports Fourth Quarter and Full Year 2023 Financial Results
Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
REDWOOD CITY, Calif., Feb. 28, 2024 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that the U.S. Food and Drug Administration (FDA) cleared its sacroiliac joint fusion device, which will be marketed as Nevro1, without the need to include the screw … [Read more...] about Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights
February 27, 2024 CARLSBAD, Calif.--(BUSINESS WIRE)-- Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter and full year ended December 31, 2023, and business highlights. Fourth Quarter and Full Year … [Read more...] about ATEC Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Highlights
SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
SANTA CLARA, Calif., Feb. 26, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Highlights (all comparisons are to the prior year period) Fiscal … [Read more...] about SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance
When will Globus Medical become the number 1 in Spine?
Globus Medical made a strategic move to challenge industry dominance by acquiring NuVasive just over a year ago. This acquisition propelled Globus from the fifth to the second position in the market. The synergy between the two companies expanded Globus's product portfolio and fortified its competitive edge in the industry. While there are notable cultural differences between … [Read more...] about When will Globus Medical become the number 1 in Spine?